Cocrystal Pharma, Inc.
COCP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $21 | $17 | $16 | $60 |
| - Cash | $10 | $26 | $37 | $59 |
| + Debt | $2 | $2 | $0 | $1 |
| Enterprise Value | $12 | -$8 | -$21 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$13 | -$15 | -$12 | -$9 |
| % Margin | – | – | – | – |
| EBITDA | -$18 | -$21 | -$18 | -$14 |
| % Margin | – | – | – | – |
| Net Income | -$18 | -$18 | -$39 | -$14 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.72 | -0.002 | -4.77 | -1.85 |
| % Growth | -90,426.3% | 100% | -157.8% | – |
| Operating Cash Flow | -$16 | -$15 | -$21 | -$13 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$16 | -$15 | -$22 | -$13 |